Item 9 Labs Corp.
INLB
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 19.69M | 19.60M | 20.57M | 21.76M | 23.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.69M | 19.60M | 20.57M | 21.76M | 23.85M |
| Cost of Revenue | 9.89M | 11.02M | 13.04M | 14.45M | 15.88M |
| Gross Profit | 9.80M | 8.58M | 7.53M | 7.31M | 7.97M |
| SG&A Expenses | 17.91M | 18.44M | 18.91M | 18.83M | 18.73M |
| Depreciation & Amortization | 1.42M | 1.48M | 1.55M | 1.61M | 2.05M |
| Other Operating Expenses | 521.80K | -247.80K | -352.20K | 0.00 | 1.46M |
| Total Operating Expenses | 29.74M | 30.69M | 33.15M | 34.88M | 38.11M |
| Operating Income | -10.04M | -11.09M | -12.57M | -13.12M | -14.26M |
| Income Before Tax | -31.04M | -30.60M | -31.06M | -31.17M | -21.73M |
| Income Tax Expenses | 11.20K | 17.20K | 16.90K | 13.20K | 7.90K |
| Earnings from Continuing Operations | -31.05 | -30.62 | -31.08 | -31.18 | -21.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 18.80K | 22.00K | 26.40K | 36.50K | 1.70K |
| Net Income | -31.03M | -30.59M | -31.06M | -31.14M | -21.74M |
| EBIT | -10.04M | -11.09M | -12.57M | -13.12M | -14.26M |
| EBITDA | -8.46M | -9.45M | -10.86M | -11.35M | -12.08M |
| EPS Basic | -0.32 | -0.31 | -0.32 | -0.32 | -0.23 |
| Normalized Basic EPS | -0.12 | -0.12 | -0.13 | -0.13 | -0.14 |
| EPS Diluted | -0.33 | -0.33 | -0.33 | -0.34 | -0.23 |
| Normalized Diluted EPS | -0.12 | -0.12 | -0.13 | -0.13 | -0.14 |
| Average Basic Shares Outstanding | 398.50M | 392.82M | 387.01M | 382.77M | 384.37M |
| Average Diluted Shares Outstanding | 398.50M | 392.82M | 387.01M | 382.77M | 384.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |